The oncogenic role of FBXO22 was shown in colorectal, liver, lung and breast cancers [20–23], while the suppressive role of cancer metastasis was also been proposed in lung cancer and breast cancer [23, 24]. The gene discussed is FBXO22; the disease is breast cancer.